Sugammadex Injection, Solution
Product Images NDC 70771-1856

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sugammadex (NDC 70771-1856). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial Label (A25a56d4 E46c 40ec A20e A31be11f91a1 01)

This appears to be a label or package insert for a medication called Sugammadex that is intended for intravenous use. The text includes information such as dosage instructions, storage conditions, and single-dose vial details. The medication is 200mg/2mL and the instructions indicate to discard any unused portion. It is important to follow the usage instructions and safety guidelines provided by a healthcare professional.*

FDA Label Image

Vial Label (A25a56d4 E46c 40ec A20e A31be11f91a1 02)

This text provides information about Sugammadex Injection in a 500 mg/5 mL single-dose vial intended for intravenous use only. It mentions storage instructions to protect from light at 25°C and details on the content of each vial. The solution contains sugammadex sodium, adjusted to a specific pH with hydrochloric acid and sodium hydroxide. The product has an osmolality between 300 and 500 mOsmol/kg. The dosage information is included in the package insert. Additionally, it refers to the manufacturer in India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.